# Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia

> **NCT07397325** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Applied Biology, Inc.** · enrollment: 60 (estimated)

## Conditions studied

- Chemotherapy Induced Alopecia
- Chemotherapy Side Effects

## Interventions

- **DRUG:** DA-020
- **DRUG:** Placebo
- **DRUG:** DA-020 and Hyperforin

## Key facts

- **NCT ID:** NCT07397325
- **Lead sponsor:** Applied Biology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-16
- **Primary completion:** 2026-10-05
- **Final completion:** 2026-12-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07397325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07397325, "Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07397325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*